{
  "title": "Characterization of osteoarthritis in cats and meloxicam efficacy using objective chronic pain evaluation tools",
  "url": "https://openalex.org/W2068025142",
  "year": 2013,
  "authors": [
    {
      "id": "https://openalex.org/A2053099400",
      "name": "Guillot M",
      "affiliations": [
        "Hôpital Notre-Dame",
        "Centre Hospitalier de l’Université de Montréal",
        "Université de Montréal"
      ]
    },
    {
      "id": "https://openalex.org/A2103815829",
      "name": "M. Moreau",
      "affiliations": [
        "Hôpital Notre-Dame",
        "Centre Hospitalier de l’Université de Montréal",
        "Université de Montréal"
      ]
    },
    {
      "id": "https://openalex.org/A2020968704",
      "name": "M. Heit",
      "affiliations": [
        "Boehringer Ingelheim (United States)"
      ]
    },
    {
      "id": "https://openalex.org/A2483606677",
      "name": "J. Martel-Pelletier",
      "affiliations": [
        "Hôpital Notre-Dame",
        "Centre Hospitalier de l’Université de Montréal"
      ]
    },
    {
      "id": "https://openalex.org/A2001505826",
      "name": "J.P. Pelletier",
      "affiliations": [
        "Centre Hospitalier de l’Université de Montréal",
        "Hôpital Notre-Dame"
      ]
    },
    {
      "id": "https://openalex.org/A2263166326",
      "name": "E. Troncy",
      "affiliations": [
        "Université de Montréal",
        "Hôpital Notre-Dame",
        "Centre Hospitalier de l’Université de Montréal"
      ]
    },
    {
      "id": "https://openalex.org/A2053099400",
      "name": "Guillot M",
      "affiliations": []
    },
    {
      "id": "https://openalex.org/A2103815829",
      "name": "M. Moreau",
      "affiliations": []
    },
    {
      "id": "https://openalex.org/A2020968704",
      "name": "M. Heit",
      "affiliations": []
    },
    {
      "id": "https://openalex.org/A2483606677",
      "name": "J. Martel-Pelletier",
      "affiliations": []
    },
    {
      "id": "https://openalex.org/A2001505826",
      "name": "J.P. Pelletier",
      "affiliations": []
    },
    {
      "id": "https://openalex.org/A2263166326",
      "name": "E. Troncy",
      "affiliations": []
    }
  ],
  "references": [
    "https://openalex.org/W2071441738",
    "https://openalex.org/W1967897673",
    "https://openalex.org/W2172200667",
    "https://openalex.org/W2133056317",
    "https://openalex.org/W2075887145",
    "https://openalex.org/W2150076351",
    "https://openalex.org/W2053045923",
    "https://openalex.org/W1939461958",
    "https://openalex.org/W1639410251",
    "https://openalex.org/W2132278120",
    "https://openalex.org/W1996213831",
    "https://openalex.org/W2064931591",
    "https://openalex.org/W1984271619",
    "https://openalex.org/W2011605357",
    "https://openalex.org/W1606439636",
    "https://openalex.org/W2038872905",
    "https://openalex.org/W2152170746",
    "https://openalex.org/W4247166048",
    "https://openalex.org/W1966247969",
    "https://openalex.org/W2094014495",
    "https://openalex.org/W2328721585",
    "https://openalex.org/W2139049840",
    "https://openalex.org/W2028873015",
    "https://openalex.org/W1985249770",
    "https://openalex.org/W2116230226",
    "https://openalex.org/W2155808565",
    "https://openalex.org/W2038332798",
    "https://openalex.org/W2043976500"
  ],
  "abstract": "This study aimed to characterize osteoarthritis (OA)-related chronic pain and disability in experimental cats with naturally occurring OA. Peak vertical ground reaction force (PVF), accelerometer-based motor activity (MA) and the von Frey anesthesiometer-induced paw withdrawal threshold were used to define OA and to test the efficacy of meloxicam. A diagnosis of OA was based on radiographic and orthopedic examinations. Cats with OA (n=39) and classified as non-OA (n=6) were used to assess the reliability and sensitivity of the parameters to assess OA over 3weeks while being administered placebo medication. A randomised parallel design study was then used to investigate the effects on OA of daily oral meloxicam treatment for 4weeks at different dose rates (0.025mg/kg, n=10mg/kg; 0.04mg/kg, n=10; 0.05mg/kg, n=9), compared to cats administered a placebo (n=10). The test-retest repeatability for each tool was good (intra-class correlation coefficient ⩾0.6). The PVF and the von Frey anesthesiometer-induced paw withdrawal threshold discriminated OA (P<0.05). Meloxicam did not add to the PVF improvement observed in placebo-treated cats during the treatment period (adj-P⩽0.01). The 0.025 and the 0.05mg/kg meloxicam-treated cats experienced a higher night-time (17:00-06:58h) MA intensity during the treatment period compared to the placebo period (adj-P=0.04, and 0.02, respectively) and this effect was not observed in the placebo group. The high allodynia rate observed in the 0.04mg/kg meloxicam-treated group may explain the lower responsiveness to the drug. The von Frey anesthesiometer-induced paw withdrawal threshold demonstrated no responsiveness to meloxicam. The results from this study indicated that daily oral meloxicam administration for 4weeks provided pain relief according to night-time MA.",
  "full_text": null,
  "topic": "Meloxicam",
  "concepts": [
    {
      "name": "Meloxicam",
      "score": 0.9173846244812012
    },
    {
      "name": "Medicine",
      "score": 0.8356204628944397
    },
    {
      "name": "Placebo",
      "score": 0.8174091577529907
    },
    {
      "name": "CATS",
      "score": 0.7176488041877747
    },
    {
      "name": "Osteoarthritis",
      "score": 0.6758544445037842
    },
    {
      "name": "Anesthesia",
      "score": 0.5749849677085876
    },
    {
      "name": "Internal medicine",
      "score": 0.3013186752796173
    },
    {
      "name": "Alternative medicine",
      "score": 0.0
    },
    {
      "name": "Pathology",
      "score": 0.0
    }
  ],
  "institutions": [
    {
      "id": "https://openalex.org/I4210142730",
      "name": "Centre Hospitalier de l’Université de Montréal",
      "country": "CA"
    },
    {
      "id": "https://openalex.org/I4210107362",
      "name": "Hôpital Notre-Dame",
      "country": "CA"
    },
    {
      "id": "https://openalex.org/I70931966",
      "name": "Université de Montréal",
      "country": "CA"
    },
    {
      "id": "https://openalex.org/I4210160255",
      "name": "Boehringer Ingelheim (United States)",
      "country": "US"
    }
  ],
  "cited_by": 118
}